← With Silex Directory
📅 Daily Calendar📦 24h JSONL ($0.05)Live 15m Pulse Board →
biomed · healthcare · X402 · 12 PERMANENT PAYWALLS

Phase-III Primary Endpoint & Biomarker Deltas

Permanent zero-subscription machine & human data library on clinical-trials.withsilex.com. Every distinct 15-minute telemetry update is archived here for all time and settles peer-to-peer in ~0.35s.

Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (14:15 UTC)2026-11-17 14:15 UTC
Recently updated NIH study NCT07941791 (NOT_YET_RECRUITING): Acute Effects of Table Tennis, Resistance Band Training, Brisk Walking, and Baduanjin on Working Memory
nct_id · phase · p_value · hazard_ratio · 6 records · +6 new primary record(s) since prior slot (NCT07941791, NCT07506655,
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (13:15 UTC)2026-11-16 13:15 UTC
Recently updated NIH study NCT07932509 (RECRUITING): Effect of Targeted Tracheal Kinesio Taping on Cough Efficacy and Decannulation Time in Burned Patients
nct_id · phase · p_value · hazard_ratio · 6 records · +6 new primary record(s) since prior slot (NCT07932509, NCT07938034,
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (14:45 UTC)2026-11-13 14:45 UTC
Recently updated NIH study NCT07936916 (NOT_YET_RECRUITING): Determinants of Physical Activity in Postmenopausal Women
nct_id · phase · p_value · hazard_ratio · 6 records · +6 new primary record(s) since prior slot (NCT07936916, NCT07154511,
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (13:15 UTC)2026-11-12 13:15 UTC
Recently updated NIH study NCT07672483 (RECRUITING): IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors
nct_id · phase · p_value · hazard_ratio · 6 records · +6 new primary record(s) since prior slot (NCT07672483, NCT07800182,
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (17:15 UTC)2026-11-11 17:15 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (17:00 UTC)2026-11-11 17:00 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:45 UTC)2026-11-11 16:45 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:31 UTC)2026-11-11 16:31 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:30 UTC)2026-11-11 16:30 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Live 15m Brief (16:26 UTC)2026-11-11 16:26 UTC
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Verified unchanged vs prior 15m check (6 active records confirmed).
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Drop #1Core Reference Vault
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Permanent Reference Vault
$0.005
Phase-III Primary Endpoint & Biomarker Deltas — Drop #2Core Reference Vault
Recently updated NIH study NCT00794352 (RECRUITING): Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
nct_id · phase · p_value · hazard_ratio · 6 records · Permanent Reference Vault
$0.006